Skip to content
LexBuild

Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Diabetes Prevention and Control in the Americas, Request for Applications (RFA) DP 06-001

---
identifier: "/us/fr/E6-9701"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Diabetes Prevention and Control in the Americas, Request for Applications (RFA) DP 06-001"
title_number: 0
title_name: "Federal Register"
section_number: "E6-9701"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Diabetes Prevention and Control in the Americas, Request for Applications (RFA) DP 06-001"
positive_law: false
currency: "2006-06-21"
last_updated: "2006-06-21"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E6-9701"
document_type: "notice"
publication_date: "2006-06-21"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "71 FR 35687"
fr_volume: 71
---

#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Diabetes Prevention and Control in the Americas, Request for Applications (RFA) DP 06-001

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following Meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Diabetes Prevention and Control in the Americas, RFA DP 06-001.

*Time And Date:* 1 p.m.-3 p.m., July 18, 2006 (Closed).

*Place:* Teleconference.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to “Diabetes Prevention and Control in the Americas,” Request for Applications (RFA) DP 06-001.

*For Further Information Contact:* J. Felix Rogers, Ph.D., M.P.H., Scientific Review Administrator, Office of Extramural Research, CDC, 4770 Buford Highway NE, Mailstop K-92, Atlanta, GA 30341, Telephone 770.488.6521.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: June 14, 2006.

Alvin Hall,

Director, Management Analysis and Services Office Centers for Disease Control and Prevention.